Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$6,585,411
in 7 filings, $4.5M under 10b5-1 plans

Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Reardon Andrew −$4.5M CLO & Secretary sold 32% of stake
  2. Aryeh Jason −$1.7M Director sold 5% of stake
  3. Zimmermann Martine −$342K Director sold 24% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-06-06 Aryeh Jason Director Grant or award · Non-Qualified Stock Option (right to buy) +5,783 5,783
2025-06-06 LAMATTINA JOHN L Director Grant or award +1,209 30,724
2025-06-06 LAMATTINA JOHN L Director Grant or award · Non-Qualified Stock Option (right to buy) +5,783 5,783
2025-06-06 Zimmermann Martine Director Grant or award +1,209 4,746
2025-06-06 Zimmermann Martine Director Shares withheld for taxes −188 $105.99 $20K 4,558
2025-06-06 Zimmermann Martine Director Grant or award · Non-Qualified Stock Option (right to buy) +5,783 5,783
2025-06-06 Sabba Stephen L Director Grant or award +1,209 33,793
2025-06-06 Sabba Stephen L Director Grant or award · Non-Qualified Stock Option (right to buy) +5,783 5,783
2025-06-06 KOZARICH JOHN W Director Grant or award +1,209 47,390
2025-06-06 KOZARICH JOHN W Director Grant or award · Non-Qualified Stock Option (right to buy) +5,783 5,783
2025-06-06 Haas Jason Director Grant or award +1,209 6,606
2025-06-06 Haas Jason Director Grant or award · Non-Qualified Stock Option (right to buy) +5,783 5,783
2025-05-15 Reardon Andrew CLO & Secretary Sale −1,000 $104.00 $104K 32,903
2025-05-09 Davis Todd C Chief Executive Officer Purchase +1,680 $104.57 $176K 153,404
2025-05-09 Davis Todd C Chief Executive Officer Purchase +2,307 $104.53 $241K 155,711
2025-05-09 Davis Todd C Chief Executive Officer Purchase +5,523 $105.67 $584K 161,234
2025-05-09 Espinoza Octavio Chief Financial Officer Purchase +1,000 $103.89 $104K 27,432
2025-05-09 Espinoza Octavio Chief Financial Officer Purchase +500 $104.40 $52K 27,932
2025-04-01 Sabba Stephen L Director Option exercise +2,406 $52.30 $126K 32,584
2025-04-01 Sabba Stephen L Director Option exercise · Non-Qualified Stock Option (right to buy) −2,406 0

Page 16 of 43 · 858 trades